Torrent Pharmaceuticals Quarterly Results for Trading Insights
TORNTPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹591 Cr
QSept 2025
Torrent Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹3,219 Cr in Sept 2025 (+11.3% vs Mar 2025, +14.4% vs Sept 2024)
- Net Profit of ₹591 Cr in Sept 2025 (+18.7% vs Mar 2025, +30.5% vs Sept 2024)
- EBITDA of ₹987 Cr in Sept 2025 (+13.2% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹17.54 in Sept 2025 (+19.2% vs Mar 2025)
Torrent Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 3,219 | 2,891 | 3,091 | 2,815 | 2,726 | 11.3% | 14.4% |
| Net Profit (₹ Cr) | 591 | 498 | 548 | 453 | 449 | - | - |
| EBITDA (₹ Cr) | 987 | 872 | 945 | 865 | 864 | - | - |
| EPS (₹) | 17.54 | 14.71 | 16.19 | 13.37 | 13.27 | - | - |
| Operating Margin (%) | 31.0% | 31.0% | 31.0% | 31.0% | 31.0% | - | - |
Torrent Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Torrent Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Torrent Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Torrent Pharmaceuticals
Additional stock information and data for TORNTPHARM
Revenue Trend (₹ Cr)
Sept 2024
2,815
Jun 2025
3,091
Mar 2025
2,891
Sept 2025
3,219
Net Profit Trend (₹ Cr)
Sept 2024
453
Jun 2025
548
Mar 2025
498
Sept 2025
591
Operating Margin Trend (%)
Sept 2024
31.0%
Jun 2025
31.0%
Mar 2025
31.0%
Sept 2025
31.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Torrent Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
|
Lupin
Sept 2025 |
₹100,719.57 Cr | 2214.3 | 6,921 | 1,485 | +23.2% | - | 21.5% | 68.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores